LiuLiang Qin - Concepedia

Author

LiuLiang Qin

Beth Israel Deaconess Medical Center ORCID

Also Known As

L.L. Qin, Linlong Qin, Liu-Liang Qin, Liu-liang Qin, LiuLiang Qin, Liuliang Qin

136

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Harvard University Mersana Therapeutics (United States)Center for Vascular Biology Research Huazhong University of Science and Technology

About

LiuLiang Qin is an author at Beth Israel Deaconess Medical Center specializing in medicine, immunotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.4K
2	Engineering	4	4	1.3K
3	Biomolecular Engineering	3	3	1.3K
4	Allergy	1	1	25
5	Biomedical Engineering	1	1	99

LiuLiang Qin

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms Akin Akinc, William Querbes, Soma De, Molecular Therapy NanotherapeuticsEngineeringImmunologyLipid NanoparticlesMolecular Biology	2010	1.1K
Orphan nuclear receptor TR3/Nur77 regulates VEGF-A–induced angiogenesis through its transcriptional activity Huiyan Zeng, LiuLiang Qin, Dezheng Zhao, The Journal of Experimental Medicine	2006	162
The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1 LiuLiang Qin, Dezheng Zhao, Jianfeng Xu, Blood	2013	104
A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy Alexander V. Yurkovetskiy, Mao Yin, Natalya D. Bodyak, Cancer Research EngineeringSmart PolymerBiomedical EngineeringImmunotherapyProtein Nanoparticles	2015	99
Down Syndrome Candidate Region 1 Isoform 1 Mediates Angiogenesis through the Calcineurin-NFAT Pathway LiuLiang Qin, Dezheng Zhao, Xin Liu, Molecular Cancer Research	2006	82
Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect Aleksandr V. Yurkovetskiy, Natalya D. Bodyak, Mao Yin, Molecular Cancer Therapeutics	2021	70
Orphan nuclear transcription factor TR3/Nur77 regulates microvessel permeability by targeting endothelial nitric oxide synthase and destabilizing endothelial junctions Dezheng Zhao, LiuLiang Qin, P Bourbon, Proceedings of the National Academy of Sciences	2011	61
Requirement of Protein Kinase D Tyrosine Phosphorylation for VEGF-A165-induced Angiogenesis through Its Interaction and Regulation of Phospholipase Cγ Phosphorylation LiuLiang Qin, Huiyan Zeng, Dezheng Zhao Journal of Biological Chemistry	2006	60
Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1 Ui Sun Park, Jian Su, Ke Chen Ban, Gene HepatologyAflatoxin B1GeneticsPathogenesisLiver Physiology	2000	50
The Dolaflexin-based Antibody–Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b Natalya D. Bodyak, Rebecca Mosher, Aleksandr V. Yurkovetskiy, Molecular Cancer Therapeutics	2021	46

Page 1